Landscapes / Companies
Zhejiang Echon Biopharm Limited not checked
FollowEvery new trial, moved date and filing, and a Monday email
Next date
None yet
Drugs
1
in active trials · 2 in all
Trials
1 active
3 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Tyrosine kinase inhibitor |
GB002, Inc., a wholly owned subsidiary of Gossamer Bio |
Phase 1 | — | ||
| How it works | Blocks a kinase | ||||
| Open drug page | |||||
About
- No active trial
- GB001
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021